Dan Sharp, Director, OTC, UT Austin

Report
The University of Texas at Austin
Office of Technology Commercialization
Creating New Approaches to Innovation
P R E S E N T E D B Y D A N S H A R P, D I R E C T O R
TO SB IR / ST T R SUMMIT & CON F ER EN C E
J A N UA RY 19 , 20 1 2
The University of Texas at Austin
 51,000+ students; 3,344 faculty
 $642MM in annual research funding
 $25.6MM/year revenue from licensing and royalty
 Over 1,000 patents filed in last 5 years
UT System ranked No. 3 by Patent Scorecard™
 $60MM industry-sponsored research from leading companies;
e.g., Abbott, Chevron, Merck, ExxonMobil, Intel, Cisco,
Samsung, BASF, Boeing, Lockheed Martin, Pfizer

Office of Technology Commercialization:
Who we are
 The Office of Technology Commercialization is responsible for




the efficient transfer of university discoveries to the marketplace
for the benefit of society. To support the university's research
mission, OTC:
Evaluates, protects, markets, and licenses the university’s
inventions and software
Promotes collaboration with industry, investors, and others
within the tech commercialization ecosystem
Informs the university's faculty on patent protection and
commercialization processes
OTC reports to the Office of the Vice President for Research
Office of Technology Commercialization:
What we do
 Initial technology disclosure evaluation and due diligence
 Patent strategy development
 Patent application and prosecution
 Business development
Interaction and negotiation with potential licensees
Marketing and faculty outreach
Tech transfer: Licensing technology to third parties
Leveraging UT technologies into funded, emerging growth
companies
License and patent enforcement





Office of Technology Commercialization:
Services we provide to you
 Legal introductions (corporate formation and funding
transactions)
 Funding introductions (angels, VCs, corporate/strategic
partners)
 Management introductions
 Seasoned entrepreneurs with solid track records and domain
expertise to develop business model and strategy
 Traditional “business development”

Leverage the collective OTC network and that of UT Austin to
accelerate market validation, feedback, and company/technology
development
 Proper handoff to the appropriate service providers/business
partner
Office of Technology Commercialization:
Cash Flow 
Where we play
Company
 Formation
Time 
Office of
Austin
Technology
Technology
Commercialization Incubator Angels
Venture Capital
Office of Technology Commercialization:
How we educate faculty
 Colloquium on Commercialization Series





October 14, 2011 – “Startup to IPO: Building for Success”
November 9, 2011 – “Licensing and Corporate Partnering”
December 6, 2011 – “Inventor of the Year Ceremony and
Reception”
February 22, 2012 – “What You Need to Know About Patents
For faculty, postdocs/grad students, and invited guests only
 To learn more, visit: www.otc.utexas.edu/Events/Colloquium/
 Send inquiries to [email protected]
Increase Quality, Not Quantity, of
Disclosures and New Patent Filings
 An iterative process with professors and students that can lead
to stronger, more prominent, and more valuable patent
portfolios
 Getting to “No” faster, in order to spend more quality time with
potential winners
 Engaging high-quality patent attorneys earlier in the process to
discuss, evaluate, and recommend optimum patent strategies
 Results
 Disclosures/patent filings
 Legal fees and administrative costs
 Revenue from higher-quality tech transfer
New US Patents Filed, FY 2010-11
COCKRELL SCHOOL OF ENGINEERING . . . . . . . . . . . . . . . . . . . .
Biomedical Engineering
11
Chemical Engineering
19
Civil, Architectural and Environmental Engineering
4
Electrical and Computer Engineering
11
Mechanical Engineering
12
Petroleum and Geosystems Engineering
8
COLLEGE OF NATURAL SCIENCES . . . . . . . . . . . . . . . . . . . . . . . .
Chemistry and Biochemistry
14
Computer Science
2
Institute for Cellular and Molecular Biology
1
Physics
1
School of Biological Sciences
10
VICE PRESIDENT FOR RESEARCH . . . . . . . . . . . . . . . . . . . . . . . .
Applied Research Laboratories (ARL)
2
Center for Electromechanics
3
Institute for Advanced Technology
1
SCHOOL OF PHARMACY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pharmaceutics
4
Pharmacy Practice
2
COLLEGE OF LIBERAL ARTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Psychology
3
0
2
4
6
8
10
12
14
16
18
20
N.B.: Total equals more than 100% of patent count because of multiple inventors in different departments.
Impact of Focus on Quality
Higher quality patent filings
200
180
160
182
155
133
140
120
FY09-10
100
80
69
60
40
20
0
Disclosures
New patent filings
FY10-11
FY 10/11 – Licensing Revenue: $25,641,730
$12,140,451
$68,693
$2,114,440
Inventors (44.1%)
Departments (8.2%)
Third Parties (0.3%)
$11,318,147
©2011, Office of Technology Commercialization
Retained by UT Austin (47.3%)
11
The Austin and Texas Technology Ecosystem
Research
and
Innovation
Technology
Development
Government and
Industry Engagement and Funding
Licensing and
New Company
Formation
Faculty and
Students
Venture
Capital
Success
Stories

similar documents